New Stock News | ACROBIOSYSTEMS plans Hong Kong IPO with revenue exceeding 600 million yuan in the first three quarters
I'm PortAI, I can summarize articles.
ACROBIOSYSTEMS announced on October 29th its plan to conduct an H-share IPO on the Hong Kong Stock Exchange to promote its internationalization strategy. The company's revenue for the first three quarters reached 613 million yuan, a year-on-year increase of 32.3%; the net profit attributable to the parent company was 132 million yuan, a year-on-year increase of 58.6%. The company focuses on biotechnology, with its main business including the research and development, production, and sales of biopharmaceuticals, involving drug development and optimization for various diseases
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments